HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Randy L Webb Selected Research

N- (1- oxo- 4- hydroxypentyl)- N- ((2'- (1H- tetrazol- 5- yl)(1,1'- biphenyl)- 4- yl)methyl)- L- valine

5/2004Effects of valsartan and valeryl 4-hydroxy valsartan on human platelets: a possible additional mechanism for clinical benefits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Randy L Webb Research Topics

Disease

4Hypertension (High Blood Pressure)
04/2015 - 11/2002
3Heart Failure
01/2017 - 11/2004
3Albuminuria
07/2008 - 06/2005
2Diabetic Nephropathies (Diabetic Nephropathy)
07/2008 - 04/2005
2Cardiomegaly (Heart Hypertrophy)
06/2005 - 11/2002
2Diabetes Mellitus
04/2005 - 08/2004
2Vascular Diseases (Vascular Disease)
05/2004 - 05/2002
1Hypertrophy
09/2008
1Vascular Remodeling
02/2008
1Stroke (Strokes)
02/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
05/2006
1Inflammation (Inflammations)
05/2006
1Ischemia
05/2006
1Fibrosis (Cirrhosis)
09/2005
1Adrenocortical Carcinoma
11/2004
1Myocardial Infarction
05/2004
1Ischemic Stroke
05/2004

Drug/Important Bio-Agent (IBA)

4Angiotensin IIIBA
02/2008 - 08/2004
4Valsartan (Vals)FDA Link
02/2008 - 11/2002
3aliskirenFDA Link
07/2008 - 02/2005
2FadrozoleIBA
09/2008 - 06/2005
2AldosteroneIBA
09/2008 - 11/2004
2CollagenIBA
09/2008 - 07/2008
2Antihypertensive Agents (Antihypertensives)IBA
07/2008 - 02/2005
2Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2006 - 08/2004
1Neprilysin (Neutral Endopeptidase)IBA
01/2017
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2017
1Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2017
1ReninIBA
04/2015
1Aspartic Acid ProteasesIBA
04/2015
1Renin InhibitorsIBA
11/2010
1Cytochrome P-450 CYP11B2 (CYP11B2)IBA
09/2008
1Spironolactone (Aldactone)FDA LinkGeneric
09/2008
1Mineralocorticoid Receptor AntagonistsIBA
09/2008
1EnzymesIBA
09/2008
1Prorenin ReceptorIBA
07/2008
1Transforming Growth Factor beta (TGF-beta)IBA
07/2008
1N- ((1- ((2- (acetylthio)- 3- methyl- 1- oxobutyl)amino)- 1- cyclopentyl)carbonyl)- O- methyl- L- tyrosine ethyl esterIBA
02/2008
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2006
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2006
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
05/2006
1DiureticsIBA
05/2006
1salicylhydroxamic acid (SHAM)IBA
05/2006
1Inflammation MediatorsIBA
05/2006
1benazepril (Briem)FDA LinkGeneric
05/2006
1Amlodipine (Norvasc)FDA LinkGeneric
05/2006
1Atrial Natriuretic Factor (ANF)IBA
09/2005
1Messenger RNA (mRNA)IBA
09/2005
1CreatinineIBA
09/2005
1Ventricular MyosinsIBA
09/2005
1Dihydrotachysterol (AT 10)IBA
04/2005
1AlbuminsIBA
04/2005
1AngiotensinsIBA
04/2005
1Vasoconstrictor AgentsIBA
11/2004
1Endothelin-1 (Endothelin 1)IBA
11/2004
1N- (1- oxo- 4- hydroxypentyl)- N- ((2'- (1H- tetrazol- 5- yl)(1,1'- biphenyl)- 4- yl)methyl)- L- valineIBA
05/2004
1EnalaprilFDA LinkGeneric
11/2002
1Nitric Oxide Synthase (NO Synthase)IBA
11/2002
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
11/2002
1Endothelins (Endothelin)IBA
05/2002
1SulfonamidesIBA
05/2002
1DipeptidesIBA
05/2002

Therapy/Procedure

1Therapeutics
11/2010